Mesenchymal stem cells
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
57
NCT03631420
Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 26, 2018
Completion: Jul 31, 2027
NCT04097652
Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke
Start: Dec 5, 2019
Completion: Dec 31, 2025
NCT04206007
Mesenchymal Stem Cells for The Treatment of Chronic Obstructive Pulmonary Disease
Start: Jun 11, 2020
Completion: Jun 30, 2024
NCT04914403
Mesenchymal Stem Cells for The Treatment of Frailty Syndrome
Start: Sep 1, 2021
Completion: Jul 31, 2025
NCT04893174
Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).
Start: Sep 15, 2022
Completion: Jun 30, 2025
NCT04347967
Mesenchymal Stem Cells for The Treatment of Acute Respiratory Distress Syndrome (ARDS)
Start: Jan 1, 2024
Completion: Sep 30, 2025
Loading map...